STRING: 561007.MAB_3131c
Mycobacterium abscessus is a rapid growing mycobacterium (RGM) that has emerged as a difficult-to-treat pathogen, especially in cystic fibrosis (CF) patients. It can cause pulmonary disease in immunocompetent individuals and shares characteristics with M. tuberculosis, including the ability to induce granulomatous lesions or caseous necrosis . M. abscessus is notorious for being highly drug-resistant to antimicrobial agents, making infections challenging to treat . The incidence of M. abscessus infections has been increasing worldwide, and in South Korea, it accounts for 70-80% of lung diseases caused by RGM .
Translation Initiation Factor IF-2 is a key protein involved in the initiation of protein synthesis. Based on studies in E. coli, infB interacts with at least three components during translation initiation: GTP, fMet-tRNA (formylmethionyl-transfer RNA), and ribosomes . It initiates the binding of fMet-tRNA to the 70S ribosome in a process involving hydrolysis of GTP to GDP, thus playing a crucial role in the correct initiation of protein synthesis . The infB gene codes for multiple forms of the IF-2 protein, with IF2α (97,300 daltons) and IF2β (79,700 daltons) being the primary variants in E. coli .
In E. coli, the infB gene contains internal in-frame initiation sites that allow for the expression of multiple forms of IF-2. The gene codes for the full-length IF2α (890 amino acids) as well as shorter forms like IF2β and IF2γ, which lack the N-terminal portions of the protein . A study of the infB gene in clinical isolates of E. coli found it to be extremely conserved, with only one polymorphic position in the deduced 890 amino acid sequence, located within the central GTP/GDP-binding domain IV of IF2 . This high conservation suggests a critical functional role for this protein in bacterial survival and growth.
Based on E. coli studies, IF-2 has a six-domain structural model. Domain I constitutes the difference between IF2α and IF2β forms. The GTP-binding domain is located within domain IV, and the C-terminal domain VI is involved in tRNA binding . The N-terminal domains (I, II, and III) have been found to be extremely conserved in E. coli clinical isolates, indicating a specific functional importance of this region . While the specific structure of M. abscessus IF-2 has not been extensively characterized, it likely shares similar domain organization with other bacterial IF-2 proteins.
In E. coli, the two major forms of IF-2 (IF2α and IF2β) differ at their N-terminus. N-terminal sequencing of purified IF2α and IF2β revealed completely different N-terminal amino acid sequences that match the DNA sequences at the beginning of the infB open reading frame and an in-phase region 471 bp downstream . These differences at the N-terminus likely affect how the protein interacts with other components of the translation machinery. Both forms retain the ability to initiate protein synthesis but may have specialized roles in different cellular contexts or under different growth conditions.
A fusion construct between the proximal half of the infB gene and the lacZ gene lacking the region coding for the first eight amino acids was created to study IF-2 forms. This fused gene expressed two products of 170,000 and 150,000 daltons, corresponding to IF2α-beta-galactosidase and IF2β-beta-galactosidase fusion proteins . Deletion of the 5'-non-translated region of the fused gene, including the Shine/Dalgarno ribosomal binding site, resulted in the expression of IF2β-beta-galactosidase but not IF2α-beta-galactosidase. This strongly suggests that IF2β results from independent translation rather than from proteolytic cleavage of IF2α .
M. abscessus has unique biological characteristics, including the ability to transition between smooth (S) and rough (R) morphotypes, which significantly affects its virulence and host immune response . This morphological transition is associated with exacerbation of disease and persistence of M. abscessus in patients . Given these unique characteristics, it's possible that IF-2 in M. abscessus has adapted specific functional attributes to support protein synthesis under the challenging conditions of host infection and antibiotic stress. Comparative studies of IF-2 across mycobacterial species would be needed to identify these potential adaptations.
M. abscessus is known for being one of the most highly drug-resistant mycobacterial species . While direct evidence linking IF-2 to antibiotic resistance in M. abscessus is lacking in the current literature, translation initiation factors could potentially contribute to resistance mechanisms. Some antibiotics target components of the translation machinery, and alterations in translation factors could affect susceptibility to these drugs. Additionally, IF-2's role in initiating protein synthesis could influence the expression of proteins involved in antibiotic resistance, such as efflux pumps or enzymes that modify antibiotics.
Studies have shown that in M. abscessus, the stringent factor Rel regulates metabolism during stress conditions . The stringent response is a conserved signaling system that promotes bacterial survival under stress by altering the transcription of about a quarter of the genome . While the specific impact on IF-2 is not documented, the stringent response typically downregulates processes related to active growth, including protein synthesis. This suggests that IF-2 activity might be modulated during stress conditions as part of the broader physiological adaptation mediated by the stringent response.
For cloning the M. abscessus infB gene, researchers should consider:
Designing PCR primers based on the published M. abscessus genome sequence, incorporating appropriate restriction sites for subsequent cloning
Using high-fidelity DNA polymerase due to the large size of the gene (~2.7 kb based on E. coli infB )
Optimizing PCR conditions for GC-rich mycobacterial DNA
Cloning into expression vectors with inducible promoters
For expression:
Consider E. coli strains specialized for expressing mycobacterial proteins
Optimize expression conditions (temperature, inducer concentration, duration)
Use fusion tags that enhance solubility (MBP, GST, SUMO) if initial expression yields insoluble protein
Consider codon optimization if expression levels are low
Based on general protein purification principles and experience with similar proteins:
Affinity chromatography using His-tag or other fusion tags is typically the first step
Ion-exchange chromatography can separate different charged species
Size exclusion chromatography helps remove aggregates and ensures homogeneity
For functional studies, consider removing tags using specific proteases
Optimize buffer conditions (pH, salt concentration, glycerol) to maintain stability during purification
Recombinant IF-2 proteins are typically purified in the presence of reducing agents to prevent oxidation of cysteine residues, and protease inhibitors to prevent degradation during the purification process.
Based on information from commercial recombinant infB products and general protein storage principles:
Store at -20°C/-80°C for long-term preservation
Add 5-50% glycerol as a cryoprotectant (50% is commonly used)
Aliquot to avoid repeated freeze-thaw cycles
The typical shelf life of liquid form is approximately 6 months at -20°C/-80°C
The shelf life of lyophilized form is approximately 12 months at -20°C/-80°C
Working concentrations typically range from 0.1-1.0 mg/mL in appropriate buffer systems .
Several methods can be employed to assess the functional activity of recombinant IF-2:
In vitro translation assays: Using purified components of the translation machinery to measure the ability of IF-2 to initiate protein synthesis
GTP binding and hydrolysis assays: Measuring the binding of radiolabeled or fluorescent GTP analogs and the rate of GTP hydrolysis
Ribosome binding assays: Assessing the interaction between IF-2 and purified ribosomes using techniques like surface plasmon resonance or filter binding assays
fMet-tRNA binding assays: Measuring the ability of IF-2 to bind formylated initiator tRNA
Dipeptide synthesis assay: An in vitro assay containing fMet-tRNA and various labeled aminoacyl-tRNAs to assess the formation of the first peptide bond, which requires functional IF-2
Researchers can study IF-2 interactions using:
Pull-down assays with tagged IF-2 to identify interacting partners
Biolayer interferometry or surface plasmon resonance to measure binding kinetics
Fluorescence anisotropy to study interactions with fluorescently labeled ligands
Isothermal titration calorimetry to determine thermodynamic parameters of binding
Cross-linking studies followed by mass spectrometry to identify interaction sites
Cryo-electron microscopy to visualize IF-2 in complex with ribosomes and other translation components
To study IF-2's potential role in morphotype transitions, researchers could:
Compare IF-2 expression levels in smooth (S) and rough (R) variants using quantitative PCR or western blotting
Create IF-2 knockdown strains using antisense RNA or CRISPR interference to assess impact on morphotype stability
Perform RNA-seq analysis of S and R variants to identify changes in IF-2-dependent gene expression
Use chromatin immunoprecipitation followed by sequencing (ChIP-seq) if IF-2 has potential regulatory roles beyond translation
Create reporter strains to monitor IF-2 expression during S to R transition, which occurs in patients with exacerbation of disease and persistence of M. abscessus
Recombinant M. abscessus IF-2 could contribute to therapeutic development through:
Structure-based drug design: Solving the crystal structure of M. abscessus IF-2 to identify potential binding pockets for small molecule inhibitors
High-throughput screening: Using purified IF-2 in functional assays to screen compound libraries for inhibitors
Rational design of peptide inhibitors that disrupt IF-2 interactions with other components of the translation machinery
Development of antibodies or aptamers that specifically target M. abscessus IF-2
Investigation of synergistic effects between IF-2 inhibitors and existing antibiotics, particularly important since M. abscessus infections are notoriously difficult to treat due to antimicrobial resistance
The transition from smooth (S) to rough (R) morphotype in M. abscessus significantly affects the host immune response . While IF-2's direct role in immune response modulation is unknown, as a central player in protein synthesis, it could influence:
Expression of bacterial surface components that interact with host immune receptors
Production of virulence factors that modulate host immunity
Adaptation to stress conditions imposed by host immune responses
The R morphotype of M. abscessus activates a stronger TLR2-mediated inflammatory response compared to the S morphotype . Studies have shown that infection with an R variant causes an inflammatory immune response that drives necrotic granuloma formation through host TNF signaling . Understanding how IF-2 functions during these different infection stages could provide insights into virulence mechanisms.
Comparative analysis of IF-2 across mycobacterial species could:
Identify unique structural features of M. abscessus IF-2 that could be exploited for species-specific targeting
Reveal evolutionary adaptations in IF-2 that correlate with pathogenicity or drug resistance
Provide insights into whether IF-2 variants contribute to the different clinical presentations of various mycobacterial infections
Guide the rational design of broad-spectrum or species-specific translation inhibitors
Such comparative studies would be particularly valuable given the increasing prevalence of M. abscessus infections and the challenges in treating them compared to other mycobacterial diseases .
Researchers face several challenges when working with recombinant M. abscessus IF-2:
Protein size: IF-2 is a large protein (approximately 97 kDa for the α form in E. coli ), which can complicate expression and purification
Solubility: Large multi-domain proteins often have solubility issues when expressed recombinantly
Functional activity: Ensuring that the recombinant protein retains its native activity after purification
Multiple forms: The presence of multiple natural forms (α, β, γ) complicates expression and functional studies
Domain interactions: The multi-domain structure may result in complex folding requirements
Future research directions could include:
Determining the crystal or cryo-EM structure of M. abscessus IF-2 in various functional states
Investigating the role of IF-2 in antibiotic tolerance mechanisms
Exploring the relationship between the stringent response and IF-2 function in M. abscessus
Developing IF-2 inhibitors as potential adjuvants to current antibiotic regimens
Creating conditional knockdown strains to study the essentiality of IF-2
Investigating the potential role of IF-2 in the formation of antibiotic-tolerant persister cells
M. abscessus infections are challenging to treat due to intrinsic and acquired antimicrobial resistance . Understanding IF-2 could contribute to treatment advances by:
Providing a new target for antimicrobial development
Identifying mechanisms of translational adaptation during antibiotic stress
Understanding how protein synthesis is regulated during infection
Developing biomarkers based on IF-2 activity or expression to monitor treatment efficacy
Creating diagnostic tools based on IF-2 sequence or activity to identify M. abscessus subspecies with different treatment outcomes (e.g., M. abscessus subsp. massiliense vs. M. abscessus subsp. abscessus, which show different treatment responses to clarithromycin-containing regimens )